Literature DB >> 32066197

A Comparison of Matching and Weighting Methods for Causal Inference Based on Routine Health Insurance Data, or: What to do If an RCT is Impossible.

Herbert Matschinger, Dirk Heider, Hans-Helmut König.   

Abstract

Due to a multitude of reasons Randomized Control Trials on the basis of so-called "routine data" provided by insurance companies cannot be conducted. Therefore the estimation of "causal effects" for any kind of treatment is hampered since systematic bias due to specific selection processes must be suspected. The basic problem of counterfactual, which is to evaluate the difference between two potential outcomes for the same unit, is discussed. The focus lies on the comparison of the performance of different approaches to control for systematic differences between treatment and control group. These strategies are all based on propensity scores, namely matching or pruning, IPTW (inverse probability treatment weighting) and entropy balancing. Methods to evaluate these strategies are presented. A logit model is employed with 87 predictors to estimate the propensity score or to estimate the entropy balancing weights. All analyses are restricted to estimate the ATT (Average Treatment Effect for the Treated) Exemplary data come from a prospective controlled intervention-study with two measurement occasions. Data contain 35 857 chronically ill insurants with diabetes, congestive heart failure, arteriosclerosis, coronary heart disease or hypertension of one German sickness fund. The intervention group was offered an individual telephone coaching to improve health behavior and slow down disease progression while the control group received treatment as usual. Randomization took place before the insurants' consent to participate was obtained so assumptions of an RCT are violated. A weighted mixture model (difference-in-difference) as the causal model of interest is employed to estimate treatment effects in terms of costs distinguishing the categories outpatient costs, medication costs, and total costs. It is shown that entropy balancing performs best with respect to balancing treatment and control group at baseline for the first three moments of all 87 predictors. This will result in least biased estimates of the treatment effect. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Entities:  

Year:  2020        PMID: 32066197     DOI: 10.1055/a-1009-6634

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  4 in total

1.  The impact of Timothy's Law on hospitalization among patients with mental health conditions in New York State.

Authors:  Mingfei Li; Victor S Y Lo; Piaomu Liu; Eric Smith
Journal:  Int J Ment Health Syst       Date:  2022-05-21

2.  Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data.

Authors:  Claudia Schulz; Gisela Büchele; Raphael S Peter; Dietrich Rothenbacher; Christian Brettschneider; Ulrich C Liener; Clemens Becker; Kilian Rapp; Hans-Helmut König
Journal:  Eur J Health Econ       Date:  2021-04-04

3.  Cardiovascular outcomes and trends of Transcatheter vs. Surgical aortic valve replacement among octogenarians with heart failure: A Propensity Matched national cohort analysis.

Authors:  Yasar Sattar; David Song; Talal Almas; Mohamed Zghouzi; Usama Talib; Abdul-Rahman M Suleiman; Bachar Ahmad; Junaid Arshad; Waqas Ullah; Muhammad Zia Khan; Christopher M Bianco; Rodrigo Bagur; Muhammad Rashid; Mamas A Mamas; M Chadi Alraies
Journal:  Int J Cardiol Heart Vasc       Date:  2022-09-15

4.  Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study.

Authors:  Diego H Farizano Salazar; Fernando Achinelli; Mariana Colonna; Lucía Pérez; Analía A Giménez; Maria Alejandra Ojeda; Susana N Miranda Puente; Lía Sánchez Negrette; Florencia Cañete; Ornela I Martelotte Ibarra; Santiago Sanguineti; Linus Spatz; Fernando A Goldbaum; Carolina Massa; Marta Rivas; Mariana Pichel; Yanina Hiriart; Vanesa Zylberman; Sandra Gallego; Brenda Konigheim; Francisco Fernández; Matías Deprati; Ian Roubicek; Diego H Giunta; Esteban Nannini; Gustavo Lopardo; Waldo H Belloso
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.